These findings suggest that select pro-inflammatory cytokines promote Rab7a activation in primary BECs in vitro, and likely in the brain vasculature, to promote degradation of BBB AJ and TJ proteins during the acute phase of ischemic stroke. Here, RAB7A is linked to ischemic stroke.